CSF3 and acute graft versus host disease: A real-world study also found that allo-HSCT mobilized with pegylated granulocyte colony-stimulating factor alleviates severe acute graft-versus-host disease by enriching M-MDSCs in the graft and is a feasible and safe treatment modality [124].